Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,933 | -2,818 | -1,488 | -873 | -6,065 |
| Depreciation Amortization | 55 | 44 | 30 | 14 | 44 |
| Income taxes - deferred | -81 | -53 | -101 | -48 | -367 |
| Accounts receivable | -121 | -103 | -259 | -116 | 3 |
| Accounts payable and accrued liabilities | 50 | 3 | 9 | -37 | -98 |
| Other Working Capital | 598 | 653 | 30 | 234 | 2,077 |
| Other Operating Activity | 297 | 635 | 382 | 228 | 3,506 |
| Operating Cash Flow | $-3,135 | $-1,639 | $-1,397 | $-600 | $-901 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -18 | -18 | -18 | -18 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | -156 |
| Other Investing Activity | -18 | -17 | -3 | 0 | 0 |
| Investing Cash Flow | $-35 | $-35 | $-21 | $-18 | $-156 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 658 | 1,846 | 1,000 | 1,000 | 181 |
| Debt Issued | 388 | 958 | 160 | 313 | 1,011 |
| Debt Repayment | 958 | -852 | -479 | -470 | -295 |
| Common Stock Issued | 1,084 | 531 | 531 | 531 | N/A |
| Other Financing Activity | 0 | 0 | 519 | 0 | 0 |
| Financing Cash Flow | $3,088 | $2,483 | $1,732 | $1,374 | $897 |
| Exchange Rate Effect | 0 | 0 | 0 | -2 | -4 |
| Beginning Cash Position | 243 | 243 | 243 | 243 | 407 |
| End Cash Position | 160 | 1,052 | 556 | 997 | 243 |
| Net Cash Flow | $-82 | $809 | $314 | $755 | $-164 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,135 | -1,639 | -1,397 | -600 | -901 |
| Free Cash Flow | -3,135 | -1,639 | -1,397 | -600 | -901 |